1
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of hepatocellular carcinoma in the Asia-Pacific
region. Gut Liver. 10:332–339. 2016. View
Article : Google Scholar : PubMed/NCBI
|
2
|
de Martel C, Maucort-Boulch D, Plummer M
and Franceschi S: World-wide relative contribution of Hepatitis B
and C viruses in hepatocellular carcinoma. Hepatology.
62:1190–1200. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Michielsen P and Ho E: Viral hepatitis B
and hepatocellular carcinoma. Acta Gastroenterol Belg. 74:4–8.
2011.PubMed/NCBI
|
5
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:pp. 3852–3856. 1976;
View Article : Google Scholar : PubMed/NCBI
|
6
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hsu MT and Coca-Prados M: Electron
microscopic evidence for the circular form of RNA in the cytoplasm
of eukaryotic cells. Nature. 280:339–340. 1979. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hentze MW and Preiss T: Circular RNAs:
Splicing's enigma variations. EMBO J. 32:923–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Wu Q, Wang Y, Cao M, Pantaleo V, Burgyan
J, Li WX and Ding SW: Homology-independent discovery of replicating
pathogenic circular RNAs by deep sequencing and a new computational
algorithm. Proc Natl Acad Sci USA. 109:pp. 3938–3943. 2012;
View Article : Google Scholar : PubMed/NCBI
|
11
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ghosal S, Das S, Sen R, Basak P and
Chakrabarti J: Circ2Traits: A comprehensive database for circular
RNA potentially associated with disease and traits. Front Genet.
4:2832013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen YT, Rettig WJ, Yenamandra AK, Kozak
CA, Chaganti RS, Posner JB and Old LJ: Cerebellar
degeneration-related antigen: A highly conserved neuroectodermal
marker mapped to chromosomes X in human and mouse. Proc Natl Acad
Sci USA. 87:pp. 3077–3081. 1990; View Article : Google Scholar : PubMed/NCBI
|
20
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang
S, Xu D, Lin HK and Gong Z: Circular RNAs in cancer: Novel insights
into origins, properties, functions and implications. Am J Cancer
Res. 5:472–480. 2015.PubMed/NCBI
|
22
|
Okuda K, Ohtsuki T, Obata H, Tomimatsu M,
Okazaki N, Hasegawa H, Nakajima Y and Ohnishi K: Natural history of
hepatocellular carcinoma and prognosis in relation to treatment.
Study of 850 patients. Cancer. 56:918–928. 1985. View Article : Google Scholar : PubMed/NCBI
|
23
|
He J, Xie Q, Xu H, Li J and Li Y: Circular
RNAs and cancer. Cancer Lett. 396:138–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Rong D, Tang W, Li Z, Zhou J, Shi J, Wang
H and Cao H: Novel insights into circular RNAs in clinical
application of carcinomas. Onco Targets Ther. 10:2183–2188. 2017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Song X, Zhang N, Han P, Moon BS, Lai RK,
Wang K and Lu W: Circular RNA profile in gliomas revealed by
identification tool UROBORUS. Nucleic Acids Res. 44:e872016.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Yang P, Qiu Z, Jiang Y, Dong L, Yang W, Gu
C, Li G and Zhu Y: Silencing of cZNF292 circular RNA suppresses
human glioma tube formation via the Wnt/β-catenin signaling
pathway. Oncotarget. 7:63449–63455. 2016. View Article : Google Scholar : PubMed/NCBI
|
27
|
Barbagallo D, Condorelli A, Ragusa M,
Salito L, Sammito M, Banelli B, Caltabiano R, Barbagallo G, Zappalà
A, Battaglia R, et al: Dysregulated miR-671-5p/CDR1-AS/CDR1/VSNL1
axis is involved in glioblastoma multiforme. Oncotarget.
7:4746–4759. 2016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Wang K, Sun Y, Tao W, Fei X and Chang C:
Androgen receptor (AR) promotes clear cell renal cell carcinoma
(ccRCC) migration and invasion via altering the
circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett.
394:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6:309192016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Huang M, Zhong Z, Lv M, Shu J, Tian Q and
Chen J: Comprehensive analysis of differentially expressed profiles
of lncRNAs and circRNAs with associated co-expression and competing
endogenous RNAs networks in bladder carcinoma. Oncotarget.
7:47186–47200. 2016. View Article : Google Scholar : PubMed/NCBI
|
31
|
Xuan LJ, Qu LM, Zhou H, Wang P, Yu H, Wu
T, Wang X, Li Q, Tian L, Liu M and Sun Y.: Circular RNA: A novel
biomarker for progressive laryngeal cancer. Am J Transl Res.
8:932–939. 2016.PubMed/NCBI
|
32
|
Yao JT, Zhao SH, Liu QP, Lv MQ, Zhou DX,
Liao ZJ and Nan KJ: Over-expression of CircRNA-100876 in non-small
cell lung cancer and its prognostic value. Pathol Res Pract.
213:453–456. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Wan L, Zhang L, Fan K, Cheng ZX, Sun QC
and Wang JJ: Circular RNA-ITCH suppresses lung cancer proliferation
via inhibiting the Wnt/β;-catenin pathway. Biomed Res Int.
2016:15794902016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lü L, Sun J, Shi P, Kong W, Xu K, He B,
Zhang S and Wang J: Identification of circular RNAs as a promising
new class of diagnostic biomarkers for human breast cancer.
Oncotarget. 8:44096–44107. 2017.PubMed/NCBI
|
35
|
Nair AA, Niu N, Tang X, Thompson KJ, Wang
L, Kocher JP, Subramanian S and Kalari KR: Circular RNAs and their
associations with breast cancer subtypes. Oncotarget.
7:80967–80979. 2016.PubMed/NCBI
|
36
|
Su H, Lin F, Deng X, Shen L, Fang Y, Fei
Z, Zhao L, Zhang X, Pan H, Xie D, et al: Profiling and
bioinformatics analyses reveal differential circular RNA expression
in radioresistant esophageal cancer cells. J Transl Med.
14:2252016. View Article : Google Scholar : PubMed/NCBI
|
37
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015. View Article : Google Scholar : PubMed/NCBI
|
38
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Li P, Chen H, Chen S, Mo X, Li T, Xiao B,
Yu R and Guo J: Circular RNA 0000096 affects cell growth and
migration in gastric cancer. Br J Cancer. 116:626–633. 2017.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Chen S, Li T, Zhao Q, Xiao B and Guo J:
Using circular RNA hsa_circ_0000190 as a new biomarker in the
diagnosis of gastric cancer. Clin Chim Acta. 466:167–171. 2017.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Tang W, Ji M, He G, Yang L, Niu Z, Jian M,
Wei Y, Ren L and Xu J: Silencing CDR1as inhibits colorectal cancer
progression through regulating microRNA-7. Onco Targets Ther.
10:2045–2056. 2017. View Article : Google Scholar : PubMed/NCBI
|
42
|
Huang G, Zhu H, Shi Y, Wu W, Cai H and
Chen X: cir-ITCH plays an inhibitory role in colorectal cancer by
regulating the Wnt/β-catenin pathway. PLoS One. 10:e01312252015.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Wang X, Zhang Y, Huang L, Zhang J, Pan F,
Li B, Yan Y, Jia B, Liu H, Li S and Zheng W: Decreased expression
of hsa_circ_001988 in colorectal cancer and its clinical
significances. Int J Clin Exp Pathol. 8:16020–16025. 2016.
|
44
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding Y and Liang L: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016. View Article : Google Scholar : PubMed/NCBI
|
45
|
Zhu M, Xu Y, Chen Y and Yan F: Circular
BANP, an upregulated circular RNA that modulates cell proliferation
in colorectal cancer. Biomed Pharmacother. 88:138–144. 2017.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Dou Y, Cha DJ, Franklin JL, Higginbotham
JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG
and Zhang B: Circular RNAs are down-regulated in KRAS mutant colon
cancer cells and can be transferred to exosomes. Sci Rep.
6:379822016. View Article : Google Scholar : PubMed/NCBI
|
47
|
Qu S, Song W, Yang X, Wang J, Zhang R,
Zhang Z, Zhang H and Li H: Microarray expression profile of
circular RNAs in human pancreatic ductal adenocarcinoma. Genom
Data. 5:385–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
48
|
Sand M, Bechara FG, Gambichler T, Sand D,
Bromba M, Hahn SA, Stockfleth E and Hessam S: Circular RNA
expression in cutaneous squamous cell carcinoma. J Dermatol Sci.
83:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
49
|
Sand M, Bechara FG, Sand D, Gambichler T,
Hahn SA, Bromba M, Stockfleth E and Hessam S: Circular RNA
expression in basal cell carcinoma. Epigenomics. 8:619–632. 2016.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Ahmed I, Karedath T, Andrews SS, Al-Azwani
IK, Mohamoud YA, Querleu D, Rafii A and Malek JA: Altered
expression pattern of circular RNAs in primary and metastatic sites
of epithelial ovarian carcinoma. Oncotarget. 7:36366–36381. 2016.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Li Y, Dong Y, Huang Z, Kuang Q, Wu Y, Li Y
and Li M: Computational identifying and characterizing circular
RNAs and their associated genes in hepatocellular carcinoma. PLoS
One. 12:e01744362017. View Article : Google Scholar : PubMed/NCBI
|
52
|
Yu L, Gong X, Sun L, Zhou Q, Lu B and Zhu
L: The circular RNA Cdr1as act as an oncogene in hepatocellular
carcinoma through targeting miR-7 expression. PLoS One.
11:e01583472016. View Article : Google Scholar : PubMed/NCBI
|
53
|
Xu L, Zhang M, Zheng X, Yi P, Lan C and Xu
M: The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of
hepatic microvascular invasion in hepatocellular carcinoma. J
Cancer Res Clin Oncol. 143:17–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
54
|
Yao Z, Luo J, Hu K, Lin J, Huang H, Wang
Q, Zhang P, Xiong Z, He C, Huang Z, et al: ZKSCAN1 gene and its
related circular RNA (circZKSCAN1) both inhibit hepatocellular
carcinoma cell growth, migration, and invasion but through
different signaling pathways. Mol Oncol. 11:422–437. 2017.
View Article : Google Scholar : PubMed/NCBI
|
55
|
Fu L, Yao T, Chen Q, Mo X, Hu Y and Guo J:
Screening differential circular RNA expression profiles reveals
hsa_circ_0004018 is associated with hepatocellular carcinoma.
Oncotarget. 8:58405–58416. 2017.PubMed/NCBI
|
56
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
57
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
58
|
Shang X, Li G, Liu H, Li T, Liu J, Zhao Q
and Wang C: Comprehensive circular RNA profiling reveals that
hsa_circ_0005075, a new circular RNA biomarker, is involved in
hepatocellular carcinoma development. Medicine. 95:e38112016.
View Article : Google Scholar : PubMed/NCBI
|